a Phase 1b/2a Study of JMT202 Injection in Participants With Hypertriglyceridemia
Clinical trial NCT07140809 · RECRUITING
Trial details
- NCT number
- NCT07140809
- Sponsor
- Shanghai JMT-Bio Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-09
- Primary completion
- 2026-07-31
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.